3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
8
Anxiety Disorders
6
Neoplasms
5
Fatigue
4
Lymphoma
3
Depression
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Nervous System Diseases
2
Lymphoma, Follicular
2
Glioma
2
Weight Loss
1
Weight Gain
1
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Substance-Related Disorders
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Mental Disorders
1
Meningioma
1
Melanoma
1
Medication Adherence
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hepatitis B
1
Interventions
Temozolomide
8
Radiotherapy
7
Radiation
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Vincristine
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Procarbazine
2
Lomustine
2
vorasidenib
1
vocimagene amiretrorepvec
1
trametinib
1
pemigatinib
1
pembrolizumab
1
mirdametinib
1
fluorodopa F 18
1
dabrafenib
1
abexinostat
1
abemaciclib
1
Vorinostat
1
Tretinoin
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Conformal
1
Protons
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
Cognitive Behavioral Therapy
×
1 year
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled